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Coronary  artery  involvement  is the  most  important  complication  of Kawasaki  disease.  Coronary  artery
bypass  surgery  has been  performed  for ischemic  heart  disease  caused  by  Kawasaki  disease,  however,
long-term  coronary  graft  patency  is not  satisfactory.  Therefore,  percutaneous  coronary  intervention  (PCI)
has  its role  in  Kawasaki  disease-related  coronary  artery  disease.  The  incidence  of  new  aneurysm  is lower
following  stent  implantation  than  balloon  dilatation  alone,  even  if a higher  balloon  pressure  is applied.
However,  there  are  few  reports  about  the efﬁcacy  of drug-eluting  stent  implantation  for  Kawasaki  dis-oronary aneurysm
ercutaneous coronary intervention
otarolimus-eluting stent
ease  with coronary  artery  disease.  Here,  we describe  a case  of  new  coronary  aneurysm  formation  and
malapposition  after  zotarolimus-eluting  stent  implantation  in  Kawasaki  disease.
<Learning objective:  New  aneurysm  formation  after  balloon  angioplasty  for coronary  artery  lesions  in
Kawasaki  disease  is  a relatively  well-known  phenomenon,  however  there  have  been  no  reports  about  the
inﬂuence  of  drug-eluting  stents  for coronary  artery  disease  with  Kawasaki  disease.  This  report  is  useful
when  we  consider  strategies  of  revascularization  for  coronary  artery  disease  with  Kawasaki  disease.>
 Jap© 2013
ase report
A 40-year-old male was  admitted to our hospital with contin-
ous precordial pain. His coronary risk factors included smoking
nd dyslipidemia. Electrocardiography showed acute anterosep-
al myocardial infarction, and urgent coronary angiography was
erformed. The culprit lesion was observed in the mid  portion
f the left anterior descending artery (LAD), which was  treated
y bare-metal stent (BMS) implantation. Coronary angiography at
he time of the intervention and 320-detector computed tomogra-
hy coronary angiography (CTCA) revealed chronic total occlusion
CTO) of the right coronary artery (RCA) and a coronary aneurysm
ith calciﬁcation considered to be associated with Kawasaki dis-
ase in the proximal portion of the RCA (Fig. 1a and b). Adenosine
tress myocardial perfusion cardiac magnetic resonance imaging
howed ischemia in the inferior wall. For this lesion, coronary
ngioplasty was performed. Two overlapping zotarolimus-eluting
tents (ZES, proximal, 3.5 mm × 24 mm;  distal, 2.5 mm × 24 mm)
ere implanted from the ostium to the mid  portion of the RCA using
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the reverse controlled antegrade and retrograde subintimal track-
ing technique (Fig. 1c). Intravascular ultrasonography (IVUS) after
stenting showed good stent expansion and apposition (Fig. 1d). It
was not necessary to use a rotational ablation. CTCA performed
6 months after coronary angioplasty revealed positive remodel-
ing of the coronary artery around the distal ZES (Fig. 2a, b and d).
Coronary angiography showed no restenosis in the BMS implanted
in the LAD, but restenosis in the ZES implanted in the RCA and
new coronary aneurysm formation around the distal ZES (Fig. 2c),
which was  consistent with CTCA ﬁndings. IVUS revealed good stent
expansion with a little neointimal proliferation, coronary aneurysm
formation, and late acquired stent malapposition (Fig. 2e). Optical
coherence tomography (OCT) performed at the same time revealed
similar ﬁndings (Fig. 2f). After coronary angiography, the restenosis
site was treated by balloon dilatation. For the coronary aneurysm,
to prevent stent thrombosis, oral administration of cilostazol was
added to aspirin and clopidogrel that had been orally administered,
and the course was  carefully observed.Discussion
The patient had a past history highly suggestive of Kawasaki dis-
ease, such as persistent fever, rash, and cervical lymphadenopathy
vier Ltd. All rights reserved.
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oig. 1. (a and b) 320-Detector computed tomography coronary angiography and c
oronary aneurysm with calciﬁcation. (c) Coronary angiography after zotarolimus
ines). (d) Intravascular ultrasound at site of arrow in (c) indicating stent distal edge
n childhood. In addition to this past history, we  predicted that
e had suffered from Kawasaki disease because of coronary
neurysm with calciﬁcation. Indications of PCI for Kawasaki disease
atients have not been established, and the long-term prognosis
n Kawasaki disease patients after PCI remains unclear. Balloon
ngioplasty is only useful for stenotic lesions with mild calciﬁ-
ation or the absence of calciﬁcation within 6 years of disease
nset [1]. However, new aneurysm formation after balloon angio-
lasty for coronary artery lesions in Kawasaki disease is a relatively
ell-known phenomenon [2,3]. The development of new coronary
neurysms that can become a risk for thrombosis is a signiﬁcant
linical concern. The mechanism responsible for this complica-
ion is unclear, however, intimal and/or medial dissection due to
igh pressure balloon inﬂation could play a role [3]. BMS  implan-
ation can reduce the incidence of restenosis and new aneurysm
ormation after coronary intervention compared with balloon
ngioplasty alone [4]. In this case, we recommended stent implan-
ation to him, because he had only 1 vessel disease after urgent
CI to LAD lesion, and venous graft to the RCA cannot be expected
o have long-term patency. We  selected a drug-eluting stent (DES)
hat can reduce the incidence of restenosis after implantation for
TO lesions compared with BMS  [5]. There are few reports about
he efﬁcacy of DES implantation for Kawasaki disease with coro-
ary artery disease. A case of coronary aneurysm formation after
irolimus-eluting stent implantation as ﬁrst generation DES in
awasaki disease has been reported [6]. ZES used in this case have a
iocompatible polymer imitating the red cell membrane, and have
xcellent long-term safety compared with ﬁrst generation DES [7].
here have been no reports of new coronary aneurysm formation
r malapposition after ZES implantation in Kawasaki disease. Thery angiography showed chronic total occlusion of the right coronary artery and a
g stents implantation (proximal, 3.5 mm × 24 mm;  distal, 2.5 mm × 24 mm,  white
ed good expansion and apposition of the stent.
cause of this complication after stent implantation is still unclear.
The mechanism of repair after vascular injury associated with inter-
ventional procedures may  differ between Kawasaki disease and
other atherosclerotic coronary disease, or hypersensitivity reac-
tions to zotarolimus, its coating polymers, or metals may  readily
occur in Kawasaki disease [6]. In this case, two  different vascular
reactions occurred in the same stent: stent restenosis and coro-
nary aneurysm formation. It is difﬁcult to describe this mechanism,
however, we  think that coronary artery speciﬁcity of Kawasaki
disease and inﬂammatory reaction after stent implantation and
interventional procedures can cause both neointimal proliferation
and coronary artery positive remodeling.
In this patient, new coronary aneurysm formation and malap-
position after ZES implantation were diagnosed using four imaging
techniques (CTCA, coronary angiography, IVUS, and OCT). New
coronary aneurysm formation and late stent malapposition after
stent implantation are a risk for stent thrombosis [8], and there is a
report of stent thrombosis after DES implantation in Kawasaki dis-
ease [9]. Therefore, we  should consider carefully the use of DES for
coronary lesions in Kawasaki disease. Based on this case and pre-
vious reports [3,4], we recommend strategies for revascularization
for coronary artery disease with Kawasaki disease as follows: (1) if
patients have multivessel coronary artery disease or chronic total
occlusion of LAD, coronary bypass surgery is recommended; (2)
if not, BMS  implantation is recommended; (3) for severe calciﬁed
coronary lesion, rotational ablation and post balloon dilatation by
low pressure are recommended; (4) DES implantation may  be one
of the choices for restenotic lesions after initial PCI. Additional cases
are necessary for the evaluation of revascularization for coronary
lesions with Kawasaki disease.
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Fig. 2. (a and b) Computed tomography coronary angiography 6 months after coronary angioplasty revealed positive remodeling of the coronary artery around the distal
zotarolimus-eluting stents (ZES). (c) Follow-up coronary angiography revealed restenosis in the ZES implanted in the right coronary artery (arrow) and marked coronary
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[neurysm formation around the distal ZES (arrow head). (d) Multi-planar recon
alapposition (arrow heads). (e and f) Intravascular ultrasound and optical coheren
alapposition (*).
onclusion
We  report a case of new coronary aneurysm formation and
alapposition after ZES implantation in Kawasaki disease. We  con-
ider that our report contributes to concepts and future directions
f coronary revascularization for Kawasaki disease.
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